Ann: Pharmaxis receives response letter from the , page-2

re: Ann: Pharmaxis receives response letter f... Whoops - this is not good news and no doubt will affect the share price over the next couple of weeks - probably a good thing that there wont be much volume going thru PXS in the next 2 weeks or so.

Deficiences at the sub-contract manufacturing level is the worry, however, without details given, it is hard to know how much of a concern this is. The other 2 problems should be fixable without too many problems. I would think this has the potential to delay things for upto 1 year, but hopefully not.